unexplained cognitive impairment who sought an Amyloid PET scan. A positive scan (presence of amyloid) indicates probably Alzheimer's (n=1746) . In addition to presenting its psychometric properties in this new sample, discussion focuses on the relationship between CAPACITY scores and a process measure of care that matters -accurate reporting of a new diagnosis. The CAPACITY score reflects an important domain of care quality that could be used more broadly to reflect the caregiver-centeredness of health care experiences and to predict patient outcomes. Despite broad appreciation of family caregivers' relevance to older adults' health care, few primary care-based interventions have incorporated mechanisms to facilitate systematic caregiver identification, screening, and support. Actionable knowledge regarding how such interventions may be incorporated into clinical practice is remarkably limited. This study used in-depth interviews to elucidate clinicians' (N=25) and caregivers' (N=20) perspectives on and suggestions for integrating caregiver screening into primary care practice. Transcripts were analyzed using qualitative content analysis. Participants emphasized the importance of tailoring the caregiver screening intervention to local circumstances and to patient and caregiver preferences. They advocated for an action-oriented approach that would link identified risks with a concrete plan for follow-up (e.g., referral to training) and outcomes relevant to the patient's care plan. Overall, participants advised that integrating the intervention into practice would require the support of multidisciplinary practice staff, stronger connections between medical and communitybased services, and appropriate reimbursement for clinicians. Family caregivers often serve as unpaid members of the home-and community-based care workforce for individuals with serious illness; as key partners in the home-clinic continuum, they should be included in healthcare teams. Without formal recognition, inconsistent identification of caregivers will remain, engendering communication gaps between caregivers and providers and difficulty connecting with supportive services. The Campaign for Inclusive Care is an initiative within the Veterans Administration Health Care System to improve practices for including caregivers in treatment planning and decisions. We define inclusive care using literature review, provider interviews, and a caregiver survey. We found that inclusive care involves clear definition of caregiver role, system policies for inclusion, assessment of caregiver capacity, explicit involvement of caregivers, and mutuality in caregiver/provider communication. We recommend solutions based on the definition, informative for development of a national caregiver strategy, required by the 2018 Recognize, Assist, Include, Support, and Engage Family Caregivers Act. The biology of aging is an immensely complex process that impacts function at the sub-cellular, cellular, tissue, organ, and whole organism levels. New technologies and systems-level approaches provide an opportunity to greatly enhance our understanding of this complexity.
FAMILY CAREGIVER SCREENING IN PRIMARY CARE: CLINICIAN AND CAREGIVER PERSPECTIVES

INCLUDING FAMILY CAREGIVERS IN SERIOUSLY ILL VETERANS' CARE: A MIXED-METHODS STUDY
SESSION 1115 (SYMPOSIUM)
SYSTEMS
SYSTEMS LEVEL UNDERSTANDING OF AGING
Vyacheslav Labunskyy 1 ,
Boston University School of Medicine, Boston, Massachusetts, United States
Aging is a complex trait is controlled by multiple genetic and environmental factors. Genome-wide screens in invertebrate organisms have led to the identification of hundreds of genes, whose deletion or knockdown can dramatically increase lifespan. Many of these genes represent conserved signaling pathways and biological processes suggesting that they might be involved in the regulation of mammalian aging. Nevertheless, the mechanistic basis by which the majority of these long-lived gene deletions extend lifespan remains poorly understood. Using yeast Saccharomyces cerevisiae as a model system, we employ systems biology network analysis of transcriptomic and protein expression data to build a detailed translational regulatory network of aging in yeast and identify genetic interactions among various aging pathways. Through these studies we expect to gain understanding how the regulatory networks are perturbed with aging, which could provide important insights into human disorders associated with the old age.
HOW MANY MOLECULAR MECHANISMS MUST BE ALTERED SIMULTANEOUSLY TO SLOW AGING AND EXTEND LIFESPAN?
Nicholas Stroustrup 1 ,
Centre for Genomic Regulation, Barcelona, Spain
Most anti-aging therapeutics are designed to target single molecules, single molecular mechanisms, or single cell types. Yet, to produce a substantial lifespan extension, these interventions would need to act promiscuously and delay the onset of many or all causes of death. In invertebrate models, several molecular-level interventions are known to act this way, yet their downstream action on multiple causes of death remains poorly understood. Recently, we identified a strong mathematical constraint in the way that many different interventions in aging alter all-cause mortality in the nematode Caenorhabditis elegans. Interventions including suppression of IGF/insulin signaling, disruption of the hsf-1 heat shock factor and the hif-1 hypoxia-inducible factor, as well as changes in diet and body temperature, all produce a temporal scaling of lifespan. This temporal scaling suggests a common physiologic path through which diverse, evolutionary-conserved, molecular mechanisms can simultaneously influence all causes of death. Cellular aging is a complex process that involves many interwoven molecular processes. Studies in model organisms have identified many individual genes and factors that have profound effects on lifespan. However, how these genes and factors interact and function collectively to drive the aging process remains unclear. We investigated single-cell aging dynamics throughout the replicative lifespans of S. cerevisiae, and found that isogenic cells diverge towards two aging paths, with distinct phenotypic changes and death forms. We further identified specific molecular pathways driving each aging fate and revealed that these pathways interact and operate dynamically to enable an early-life switch that governs the aging fate decision and the progression towards death. Our work uncovers the interconnected molecular pathways that drives the aging process and opens up the possibility of designing interventions that simultaneously target multiple network nodes, instead of single genes, to more effectively extend the healthspan. Aging causes the global disorganization of nuclear chromatin architecture. In a normal young nucleus, silent heterochromatin is associated with the nuclear lamina layer underlying nuclear envelope, thus spatially separated from euchromatin at the nuclear center. Notably, aging causes the disruption of nuclear lamina and the decondensation of associated heterochromatin. However, it is not clearly understood how these changes of chromatin architectures contribute to age-related diseases. Through large-scale computational analyses, we present that CpG islands (CGIs) give important clues to answering this question. CGIs are DNA elements with high Cytosine-phosphate-Guanine dinucleotide frequencies. In human, about 60% of total genes contain CGIs at their promoters (CGI+ genes) and are broadly expressed throughout the body. The other 40% of genes that do not have CGIs (CGI-genes) exhibit tissue-restricted expression patterns. Our results demonstrate that, in normal young nuclei, only CGI-genes can reside within lamina-associated heterochromatin when transcriptionally inactive, while CGI+ genes associate with nuclear central euchromatin even when they are repressed. In parallel, we show that age-associated heterochromatin decondensation can specifically de-repress tissuespecific CGI-genes leading to their uncontrolled expressions. Our results further demonstrate that global misregulation of CGI-genes increases the noise in gene transcription that, in turn, causes the loss of cellular identities during aging. Taken together, our study establishes critical implication of CGImediated chromatin architecture in age-associated degenerative changes and loss of tissue homeostasis. The Longevity Consortium (LC), a NIA-Cooperative project, is an integrated multi-disciplinary effort with cutting edge bioinformatic, systems biology and chemoinformatics approaches exploiting multiple omics data generated from multiple well-phenotyped aging cohorts, Study of Osteoporotic Fractures, MrOS (fractures in men), Cardiovascular Health Study, the Long Life Family Study and the Centenarian Project to discover pharmacologically targetable protective pathways that promote healthy aging. Omics studies of mice treated with candidate drugs and of multiple species with varying life spans further informs the LC efforts. We describe the integration of the above efforts and the LC goals as well as opportunities for interested investigators to access shared results as well as opportunity funds for pilot projects. Early successes are described in 4 presentations: (1) A genomewide association study including 1317 centenarians discovered 8 new loci in chromosomes 3, 6, 7, 9, 10, 14 and 15. The list includes new serum pQTLs that suggest a new biological mechanism involved in extreme longevity. (2) Novel, high-throughput discovery-proteomics of serum from 2,473 MrOs participants identified 25 proteins, mostly found in inflammatory pathways, associated with living beyond the 90th percentile birth-cohort survival. (3) A biological age estimation algorithm utilizing multi-omics assays significantly differentiated between 3,558 wellness program participants and controls. (4) Mediation analyses were used to test causal relationships between many candidate aging-modulating drugs and compounds, expression levels of gene and protein variants (eQTLs and pQTLs) and aging and longevity phenotypes. This high throughput method shows promise as a means of discovering candidate drugs for healthy aging. California Pacific Medical Center Research Institute, San Francisco, California, United States, 2. California Pacific Medical Center Research Institute, UCSF, San Francisco, California, United States, 3. San Francisco Coordinating Center, CPMCRI, UCSF, San Francisco, California, United States, 4. TGen, Phoenix, Arizona, United States Molecular factors and pathways promoting human longevity and healthy aging can potentially delay or prevent multiple chronic diseases and conditions, but identifying such factors that can be pharmacologically targeted requires an integrated multidisciplinary approach. We describe the design of the five research projects and three cores of the
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